SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Snap, Inc. is a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

Snap is currently trending as investors debate the sustainability of its recent earnings-driven momentum, weighing strong user engagement and AR/AI hardware potential against ongoing legal challenges and historical insider selling pressure. While the community remains deeply polarized over leadership's long-term strategy, significant focus is directed toward the company's ability to maintain monetization growth and navigate a dense landscape of litigation.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Sellas Life Sciences is currently trending as investors eagerly await the 80th event in the Phase 3 REGAL trial, an event-driven catalyst that will trigger final data unblinding and analysis. The community is actively debating the significance of the extended trial timeline and recent institutional accumulation, with many interpreting the prolonged wait for final survival events as a sign of GPS's potential efficacy against AML.

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

Ocular Therapeutix is trending as investors digest a major regulatory milestone, where the FDA confirmed the company can submit an NDA for its wet AMD treatment, AXPAXLI, based on single-trial data without requiring efficacy results from the ongoing SOL-R study. While bulls are celebrating this de-risking event and anticipating a potential buyout or partnership ahead of the planned fourth-quarter filing, short sellers remain active, driving intense debate over the stock's valuation, trial design, and management's timeline.

Baidu, Inc. engages in the provision of internet search and online marketing solutions. The firm’s products and services include Baidu App, Baidu Search, Baidu Feed, Haokan, Quanmin, Baidu Post Bar, Baidu Knows, Baidu Encyclopedia, Baidu Input Method Editor or Baidu IME, Baidu AI Cloud and Overseas Products. It operates through the following segments: Baidu Core and iQIYI. The Baidu Core segment provides search-based, feed-based, and other online marketing services. The iQiyi segment is an online entertainment service provider, which offers original, professionally produced and partner-generated content on its platform. The company was founded by Yanhong Li and Xu Yong on January 18, 2000 and is headquartered in Beijing, China.

Baidu Inc - ADR

Baidu is seeing significant attention as investors react to reports of a potential high-valuation IPO for its AI chip subsidiary, Kunlunxin, while the community remains divided over whether to capitalize on this AI growth catalyst or exit positions amid ongoing concerns regarding Chinese tech sector regulations and performance. Investors are actively debating the stock's long-term potential as an undervalued AI and cloud infrastructure play versus its historical status as a volatile value trap.

EyePoint, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that treat eye disorders. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands. The company was founded in 1987 and is headquartered in Watertown, MA.

EyePoint Inc.

EyePoint Pharmaceuticals Inc

EyePoint Pharmaceuticals is trending after its pivotal Phase 3 LUGANO trial for DURAVYU in wet AMD failed to meet the primary endpoint in the full dataset, though the company noted success in an ad hoc analysis excluding certain patients. The community is actively discussing the stock's future, with some investors focusing on the potential for a buyout, while others are analyzing the competitive threat to firms like Ocular Therapeutix and speculating on whether the trial failure warrants a short squeeze or a further decline.

Aventus Network

Aventus Network is experiencing extreme volatility and intense community scrutiny following reports of a potential supply increase and challenges with exchange buy orders, leading to widespread speculation of a pump-and-dump scheme. While some investors remain optimistic about the project's long-term utility and infrastructure focus, others are concerned by the suspicious trading patterns and liquidity issues impacting holders.

Vanguard Index Funds - Vanguard S&P 500 ETF

Vanguard S&P 500 ETF

Vanguard S&P 500 ETF (VOO) is trending as investors weigh strong corporate earnings and AI-driven growth against ongoing macroeconomic uncertainty, geopolitical tensions, and debates over Fed interest rate policy. Community sentiment remains divided between those prioritizing long-term passive accumulation and those expressing concern over potential market overvaluation and broader economic risks.

SentinelOne, Inc. engages in the provision of endpoint security software that detects, models, and predicts threat behavior to block attacks on any computing device. Its services include vigilance, support, and training. The company was founded by Tomer Weingarten and Almog Cohen in 2013 and is headquartered in Mountain View, CA.

SentinelOne Inc - Ordinary Shares - Class A

SentinelOne Inc

SentinelOne is trending as investors weigh its deep undervaluation relative to peers like CrowdStrike and Palo Alto Networks against a backdrop of increasing institutional interest and potential acquisition speculation. The community is actively debating the company's growth prospects, its strategic technology partnerships, and its potential as a buyout target within the cybersecurity consolidation cycle.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is trending due to optimistic investor sentiment surrounding the company's progress toward a Q4 BLA submission for its prostate cancer immunotherapy, aglatimagene besadenovec. The community is actively discussing clinical trial data, the potential for a multibillion-dollar market opportunity, and ongoing institutional accumulation as stakeholders position themselves for potential M&A or long-term commercial growth.

Zscaler, Inc. engages in the provision of a cloud-based internet security platform. It offers Zero Trust Exchange, Zscaler Client Connector, Zscaler Internet Access, Zscaler Private Access, Zscaler B2B, Zscaler Cloud Protection, and Zscaler Digital Experience. The company was founded by Jagtar Singh Chaudhry and K. Kailash in September 2007 and is headquartered in San Jose, CA.

Zscaler Inc

Zscaler is trending as analysts from firms like Wells Fargo and TD Cowen raise price targets, citing robust security demand and sustained institutional accumulation despite recent volatility. Community sentiment remains bullish, with traders eyeing a technical breakout toward the $200 level, bolstered by the stock's relative strength and growing enterprise adoption of its zero-trust security platform.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
